IV Care Options Funding: How Much Did They Raise & Key Investors

How Much Did IV Care Options Raise?
Funding & Key Investors

IV Care Options, operating under the Palmetto Infusion Services brand, has solidified its market presence through a significant capital infusion. The organization has secured a total of $1M in financing, with the most recent strategic investment totaling $1M. This influx of capital underscores the company's robust growth trajectory and its commitment to expanding its footprint in the specialized healthcare sector.

By leveraging this financial backing, the firm continues to scale its operations, ensuring that its high-quality infusion and injection services remain accessible to a growing patient base across the Southeast. The recent funding round serves as a testament to the company's operational efficiency and its ability to attract institutional interest in a competitive medical landscape.

What is IV Care Options?

IV Care Options

Healthcare Services

Elderly Care Services

Palmetto Infusion Services, the primary operational entity of IV Care Options, is a leader in the delivery of clinic and home-based infusion and injection therapies. With a network spanning over 40 locations, the company provides essential care for patients managing both acute and chronic conditions. Their service model is built on the pillars of cost-effectiveness, clinical excellence, and 24/7 support, distinguishing them as the premier provider in the region. By serving more than 20,000 patients annually, the company has established a scalable infrastructure that bridges the gap between hospital-based care and patient-centric home environments.

How much funding has IV Care Options raised?

IV Care Options has raised a total of $1M across 1 funding round:

2020

Debt

$1M

Debt (2020): $1M with participation from PPP

Key Investors in IV Care Options

PPP

Public-Private Partnership

What's next for IV Care Options?

With the support of this major enterprise-level funding, IV Care Options is well-positioned to accelerate its strategic expansion. The focus will likely shift toward enhancing its digital health integration, optimizing supply chain logistics for specialized medications, and potentially entering new geographic markets to replicate its successful Southeast model. As the demand for outpatient infusion services continues to rise, the company's ability to maintain high-touch, personalized care while scaling its operational capacity will be critical. Future growth will likely involve further investment in clinical talent and advanced patient management systems to maintain its market-leading position.

See full IV Care Options company page

See More Financial Insights